| 1. |
Celli BR, MacNee W. ATS/ERS Task Force, Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J, 2004, 23(6): 932-946.
|
| 2. |
Global initiative for obstructive lung disease-updated 2007. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. www.goldcopd.org.
|
| 3. |
Bradley SQ, Wen QG, Don DS. Contemporary management of acute exacerbations of COPD. Chest, 2008, 133(3): 756-766.
|
| 4. |
The Evidence-Based Medicine Working Group. Users’ Guides to the Medical Literature: A Mannual for Evidence Based Clinical Practice. Chicago: AMA Press. 2002.
|
| 5. |
Maltais F, Ostinelli J, Bourbeau J, et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2002, 165(5): 698-703.
|
| 6. |
Mirici A, Akgun M. Comparison of the efficacy of nebulized budesonide with parenteral corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Clin Drug Invest, 2003, 23(1): 55-62.
|
| 7. |
Gunen H, Hacievliyagil SS, Yetkin O, et al. The role of nebulized budesonide in the treatment of exacerbations of COPD. Eur Respir J, 2007, 29: 660-667.
|
| 8. |
舒德芬, 杨中华, 张艳玲, 等. 雾化吸入布地奈德和泼尼松龙静脉用药治疗老年COPD急性加重期的对比研究. 四川大学学报(医学版), 2009, 40(1): 172-174.
|
